Roanoke Asset Management’s Pfizer PFE Stock Holding History

Roanoke Asset Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-8,237	Closed	-$265K	–	99
2016 Q3	$265K	Hold	8,237	–	–	0.12%	86
2016 Q2	$275K	Hold	8,237	–	–	0.13%	85
2016 Q1	$232K	Hold	8,237	–	–	0.11%	89
2015 Q4	$252K	Sell	8,237 -11,304	-58%	-$356K	0.11%	90
2015 Q3	$582K	Hold	19,541	–	–	0.21%	79
2015 Q2	$622K	Buy	+19,541	New	+$637K	0.2%	78

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Roanoke Asset Management's PFE Position: Q4 2016 in Review

Roanoke Asset Management sold out of Pfizer (PFE) in Q4 2016, closing a stake of 8,237 shares — an estimated $265K sold.

Roanoke Asset Management first reported a position in PFE in Q2 2015 and held it in 6 quarters. The position peaked at $622K in Q2 2015. 2,059 funds tracked by Wall St. Rank hold PFE as of Q4 2016.

Roanoke Asset Management reported no remaining Pfizer position as of Q4 2016 after selling out during the quarter.
Roanoke Asset Management sold 8,237 Pfizer shares in Q4 2016, an estimated $265K.
Roanoke Asset Management first reported a position in Pfizer in Q2 2015 and held it in 6 quarters.
Roanoke Asset Management's Pfizer position peaked at $622K in Q2 2015.
2,059 funds tracked by Wall St. Rank held Pfizer as of Q4 2016.

Based on Roanoke Asset Management's 13F filing for Q4 2016, filed 7 Feb 2017.